Eye Disease & Ophthalmology Clinical Trials Update: Week 32, 2026

Published August 7, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

This Phase 2 trial is testing GAL-101 eye drops for patients with non-foveal geographic atrophy caused by age-related macular degeneration. The goal is to see if daily use of these eye drops can slow down the growth of damaged areas in the retina, potentially preserving vision for a longer time. The study is actively recruiting participants in multiple countries, offering hope for a treatment that targets vision loss in this condition.

Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy

This early-stage trial is exploring a gene-editing injection called GEB-101 for adults with a hereditary form of corneal dystrophy linked to TGFBI gene changes. If successful, this treatment could address the root genetic cause of the disease, possibly improving vision and slowing disease progression. The study plans to enroll 30 participants in the United States and China but has not started recruiting yet.

Robotic OCT for ER Anterior Eye Exams

This study is testing a robot-assisted imaging system designed to examine the front part of the eye in emergency room settings. The system aims to improve how quickly and accurately eye exams can be done in urgent care, which may lead to faster treatment and better outcomes for patients with eye injuries or sudden vision problems. The trial is currently recruiting 93 participants in the United States.

Predicting Intraocular Lens Tilt Using OCT Measurements and Partial Least Squares Regression Modelling

This completed study looked at a new imaging method to predict how intraocular lenses might tilt after cataract surgery. Better prediction of lens tilt could help doctors understand and potentially prevent vision issues following surgery. The research involved 110 participants in Austria and may influence future approaches to cataract care.

Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot Study

This pilot study is examining how intense endurance exercise, like ultra-trail running, affects blood flow in the eye. Using noninvasive imaging before and after the race, researchers hope to learn more about how physical stress impacts eye health and circulation. The study is recruiting healthy adult participants in France.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.